scholarly journals CLINICOPATHOLOGICAL FEATURES OF PATIENTS WITH LYMPH NODE METASTASIS AT THE SPLENIC HILUM AND INDICATION OF SPLENECTOMY FOR ADVANCED GASTRIC CANCER IN THE UPPER THIRD OF THE STOMACH

2003 ◽  
Vol 64 (11) ◽  
pp. 2671-2676
Author(s):  
Kazuhito UEMURA ◽  
Yukifumi KONDO ◽  
Kuniaki OKADA ◽  
Hiroyuki ISHIZU ◽  
Shohei OSAWA ◽  
...  
Oncotarget ◽  
2017 ◽  
Vol 8 (48) ◽  
pp. 84515-84528 ◽  
Author(s):  
Taeil Son ◽  
In Gyu Kwon ◽  
Joong Ho Lee ◽  
Youn Young Choi ◽  
Hyoung-Il Kim ◽  
...  

2015 ◽  
Vol 19 (2) ◽  
pp. 531-542 ◽  
Author(s):  
Keishi Yamashita ◽  
Atsushi Kuno ◽  
Atsushi Matsuda ◽  
Yuzuru Ikehata ◽  
Natsuya Katada ◽  
...  

2001 ◽  
Vol 16 (5) ◽  
pp. 581-585 ◽  
Author(s):  
Kaori Shigemitsu ◽  
Yoshio Naomoto ◽  
Tsuyoshi Matsuno ◽  
Akira Gochi ◽  
Hiroshi Isozaki ◽  
...  

2017 ◽  
Vol 35 (4_suppl) ◽  
pp. 28-28
Author(s):  
Jeunghui Pyo ◽  
Hyuk Lee ◽  
In Seub Shin ◽  
Tae Jun Kim ◽  
Yang Won Min ◽  
...  

28 Background: The clinicopathological features of mixed type (MT) early gastric cancer (EGC) according to Lauren’s classification remain uninvestigated. This study aimed to clarify the clinicopathological features of MT EGC, particularly in relation to lymph node metastasis (LNM) and long-term survival. Methods: This study included 5,309 patients who underwent gastrectomy for EGC. The clinicopathological features, LNM, and long-term outcomes of patients with MT carcinomas were compared to those with intestinal type (IT) and diffuse type (DT) cancers. Furthermore, we evaluated the predictors of LNM in each Lauren classification subgroup. Results: Patients with MT carcinomas were more likely to have larger tumors, submucosal invasion, lymphovascular invasion (LVI), and LNM compared to those with IT or DT carcinomas. Multivariate logistic regression analysis revealed that Lauren’s classification was a significant predictor of LNM ( P < 0.001). The significant predictors of LNM in MT carcinomas were female sex, greater tumor size, presence of submucosal invasion, and LVI. However, the overall survival of patients with MT carcinoma was not significantly different from that of patients with IT or DT carcinomas ( P= 0.104). Conclusions: The presence of MT EGC carries a higher risk of LNM compared to IT or DT carcinomas. Therefore, MT carcinomas should be managed with gastrectomy that includes lymph node dissection instead of endoscopic resection.


2017 ◽  
Vol 30 (2) ◽  
pp. 161-168 ◽  
Author(s):  
Hajime Fujishima ◽  
Yoshitake Ueda ◽  
Norio Shiraishi ◽  
Takao Hara ◽  
Michihiro Ichimanda ◽  
...  

2019 ◽  
Vol 37 (4_suppl) ◽  
pp. 56-56
Author(s):  
Takashi Oshima ◽  
Yohei Miyagi ◽  
Naohide Oue ◽  
Munetaka Masuda ◽  
Yayoi Kimura

56 Background: The outcomes of patients with locally advanced gastric cancer who have highly advanced lymph node metastasis such as N3 remain poor despite radical resection. If the preoperative diagnoses of such patients improve, further improvement in treatment outcomes is expected to be obtained by means of personalized therapies such as preoperative chemotherapy; however, the accuracy of diagnosis remains unsatisfactory. Therefore, exploratory proteome analysis using sera was performed with the aim of developing a supplementary liquid-biopsy-based technique to diagnose highly advanced lymph node metastasis in patients with locally advanced gastric cancer. We report the results obtained thus far. Methods: The subjects were 24 patients with pT4a gastric cancer (12 with pN0 disease and 12 with pN3 disease). Proteins that had significantly different (P<0.001) expression levels in the preoperative serum on exploratory proteome analysis by liquid chromatography and mass spectrometry were identified. These proteins were verified by Enzyme-Linked ImmunoSorbent Assay (ELISA) using a different cohort (20 patients with pN0 disease and 13 with pN3 disease) from that described above. Results: In the exploratory proteome analysis, 2,357 kinds of proteins were identified and examined. Six these proteins were identified as candidate predictive markers of highly advanced lymph node metastasis. These proteins were verified using existing and newly developed ELISA kits, and reproducibility was verified for one protein (Protein V) (P = 0.003). Conclusions: The possibility of the supplementary diagnosis of highly advanced lymph node metastasis by liquid biopsy was suggested in patients with locally advanced gastric cancer. Further evaluations by prospective studies are now in progress, with the ultimate goal of clinical application.


Sign in / Sign up

Export Citation Format

Share Document